People's United Financial’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Other funds holding REGN
People's United Financial's REGN Position: Q1 2022 in Review
People's United Financial reduced its Regeneron Pharmaceuticals (REGN) stake by 41% in Q1 2022, selling an estimated $782K and leaving 1,757 shares worth $1.23M. The position accounts for 0.03% of the portfolio, ranked #301.
People's United Financial first reported a position in REGN in Q3 2015 and has held it in 20 quarters since. The position peaked at $1.89M in Q4 2021. 1,095 funds tracked by Wall St. Rank hold REGN as of Q1 2022.
- People's United Financial held 1,757 shares of Regeneron Pharmaceuticals worth $1.23M as of Q1 2022.
- People's United Financial sold 1,236 Regeneron Pharmaceuticals shares in Q1 2022, an estimated $782K.
- Regeneron Pharmaceuticals made up 0.03% of People's United Financial's portfolio in Q1 2022, its #301 holding.
- People's United Financial first reported a position in Regeneron Pharmaceuticals in Q3 2015 and has held it in 20 quarters since.
- People's United Financial's Regeneron Pharmaceuticals position peaked at $1.89M in Q4 2021.
- 1,095 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2022.
Based on People's United Financial's 13F filing for Q1 2022, filed 10 May 2022.